Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: Screening of their biological activities against Ca2+-ATPase

European Journal of Medicinal Chemistry
2012.0

Abstract

A regioselective N1-alkylation of 3,4-dihydropyrimidin-2(1H)-ones using a very efficient mild base Cs(2)CO(3) and alkyl halides at room temperature has been reported. The selectivity of this methodology is excellent and the yields of the alkylated products are very good. Furthermore inhibitory action of both the 3,4-dihydropyrimidin-2(1H)-ones and the N1-alkylated derivatives were tested on Ca(2+)-ATPase, which revealed that the parent compounds can act as Ca(2+)-ATPase inhibitors whereas the N1-alkylated derivatives are inefficient for this purpose.

Knowledge Graph

Similar Paper

Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: Screening of their biological activities against Ca2+-ATPase
European Journal of Medicinal Chemistry 2012.0
N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity
European Journal of Medicinal Chemistry 2009.0
Highly regioselective synthesis of N-3 organophosphorous derivatives of 3,4-dihydropyrimidin-2(1H)-ones and their calcium channel binding studies
European Journal of Medicinal Chemistry 2012.0
Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and anti-hypertensive activity
Journal of Medicinal Chemistry 1989.0
Selective α1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones
Bioorganic & Medicinal Chemistry Letters 2000.0
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents
Journal of Medicinal Chemistry 1992.0
Dihydropyrimidine calcium channel blockers 51: bicyclic dihydropyrimidines as potent mimics of dihydropyridines
Bioorganic & Medicinal Chemistry Letters 1991.0
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A<sub>2B</sub> Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and Enantiospecific Recognition
Journal of Medicinal Chemistry 2021.0
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines
Journal of Medicinal Chemistry 1990.0